methadone has been researched along with Smoking Cessation in 67 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to evaluate the efficacy of varenicline directly observed therapy (DOT) on varenicline adherence and smoking cessation rates among smokers with opioid use disorder (OUD) receiving methadone treatment." | 9.41 | Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial. ( Adams, TR; Arnsten, JH; Nahvi, S; Ning, Y; Zhang, C, 2021) |
| "We test, using a three-group randomized design, the efficacy of varenicline versus placebo, in comparison with nicotine replacement therapy (NRT) that combines nicotine patch prescription plus ad libitum nicotine rescue, for smoking cessation." | 9.17 | Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. ( Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD, 2013) |
| "To determine predictors of smoking cessation duration in a randomized clinical trial, we assigned participants to nicotine patch (8-12 weeks) plus either (a) a baseline tailored brief motivational intervention, a quit date behavioral skills counseling session, and a relapse prevention follow-up session, or (b) brief advice using the National Cancer Institute's 4A's model." | 9.12 | Smoking cessation patterns in methadone-maintained smokers. ( Anderson, BJ; Niaura, R; Stein, MD, 2007) |
| "To test, in combination with the nicotine patch, the incremental efficacy of a maximal, tailored behavioral treatment over a minimal treatment for smoking cessation." | 9.12 | A smoking cessation intervention for the methadone-maintained. ( Anderson, BJ; Anthony, JL; Herman, DS; Niaura, R; Stein, MD; Weinstock, MC, 2006) |
| "The relationship between tobacco and illicit drug use was examined among 166 methadone-maintained persons participating in a smoking cessation intervention." | 9.10 | Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained. ( Frosch, DL; Shoptaw, S; Stein, JA, 2002) |
| "To evaluate relapse prevention (relapse prevention) and contingency management (contingency management) for optimizing smoking cessation outcomes using nicotine replacement therapy for methadone-maintained tobacco smokers." | 9.10 | Smoking cessation in methadone maintenance. ( Frosch, D; Jarvik, ME; Ling, W; Nahom, D; Rawson, RA; Rotheram-Fuller, E; Shoptaw, S; Yang, X, 2002) |
| "Individuals in methadone maintenance treatment are motivated to quit smoking and are interested in smoking cessation treatment." | 8.86 | Smoking cessation interventions among individuals in methadone maintenance: a brief review. ( Barr, AM; Greaves, L; Johnson, JL; Khara, M; Okoli, CT; Procyshyn, RM, 2010) |
| "Over 80% of people in methadone treatment smoke cigarettes, and existing smoking cessation interventions have been minimally effective." | 7.81 | Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment. ( Bernstein, SL; Cooperman, NA; Richter, KP; Steinberg, ML; Williams, JM, 2015) |
| "Smoking cessation treatment service is concerned to be a critical element in methadone maintenance treatment (MMT) in order to diminish the effect of smoke on health outcomes." | 7.81 | Motivation for smoking cessation among drug-using smokers under methadone maintenance treatment in Vietnam. ( Do, HP; Dunne, M; Latkin, C; Nguyen, LH; Nguyen, NP; Phan, HT; Tran, BX, 2015) |
| "The need for research to develop and test tailored interventions for this population is highlighted, as is the need for methadone services and staff to facilitate client smoking cessation." | 7.78 | Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action. ( Bartlem, K; Bowman, J; Colyvas, K; Walsh, RA; Wiggers, J; Wye, P, 2012) |
| "To report the potential clinically significant pharmacokinetic interaction that may result from smoking cessation in patients on methadone maintenance therapy." | 7.77 | Methadone toxicity due to smoking cessation--a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2. ( Kolluru, S; Molina, C; Nguyen, T; Speake, J; Wahawisan, J, 2011) |
| "Our data show a higher level of nicotine dependence and depression, and greater readiness to change among women smokers in methadone maintenance programmes compared to women smokers attending primary care clinics." | 7.76 | Nicotine dependence and depression among women smokers on methadone maintenance. ( Arnold, S; Gandhi, D; Joshi, A; Khanna, N; Sadaphal, S; Stewart, D, 2010) |
| "This study was aimed at assessing feasibility and patient acceptance of an interactive educational module of a multi-component smoking cessation counseling computer program for former illicit drug users treated in an outpatient methadone clinic." | 7.74 | Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education. ( Cha, E; Finkelstein, J; Lapshin, O, 2008) |
| "There was described and discussed a case of methadone maintenance participant, former polydrug abuser, who has received a standard treatment with bupropion SR for smoking cessation." | 7.73 | [Bupropion in cigarettes smoking cessation by former polydrug user participating in methadone maintenance programme]. ( Habrat, B; Steinbarth-Chmielewska, K, 2005) |
| "Little is known about how well methadone programs address smoking cessation." | 7.73 | Addressing smoking cessation in methadone programs. ( Alford, DP; Horton, NJ; Olsen, Y; Saitz, R, 2005) |
| " In the 30 days before the survey, respondents reported that their clinics provided the following services to at least one patient: 73 percent provided brief advice to quit, 18 percent offered individual or group smoking cessation counseling, and 12 percent prescribed nicotine replacement therapy." | 7.72 | Smoking cessation services in U.S. methadone maintenance facilities. ( Ahluwalia, JS; Choi, WS; Harris, KJ; McCool, RM; Richter, KP, 2004) |
| "Several studies have shown high levels of interest in smoking cessation among methadone maintained heroin users, yet little is known about how to intervene most effectively with this population." | 7.71 | Optimizing smoking cessation outcomes among the methadone maintained. ( Frosch, DL; Nahom, D; Shoptaw, S, 2002) |
| " Because a history of depression has been shown in other populations to complicate cessation efforts, the relationship between depression and nicotine dependence was tested in 726 methadone patients." | 7.69 | Nicotine dependence and depression among methadone maintenance patients. ( Brown, LS; Lin, MM; Meyer, TJ, 1996) |
| "Methadone maintenance treatment (MMT) patients have an exceedingly high prevalence of tobacco use, and interventions that have been specifically developed for this vulnerable subpopulation have struggled to attain even modest rates of cessation." | 6.79 | Early quit days among methadone-maintained smokers in a smoking cessation trial. ( Anderson, BJ; Caviness, CM; de Dios, MA; Stein, MD, 2014) |
| "Nicotine use disorder is highly prevalent among methadone maintenance patients with its tobacco-related problems." | 6.58 | Smoking Cessation Among Methadone-Maintained Patients: A Meta-Analysis. ( Hoong, MC; Joyce, YC; Loh, HS; Yee, A, 2018) |
| "Over 85% of opioid-dependent individuals in methadone treatment smoke cigarettes; however, smoking cessation interventions are minimally effective in this population." | 5.27 | Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence. ( Bernstein, SL; Cooperman, NA; Lu, SE; Richter, KP; Williams, JM, 2018) |
| "To test the efficacy and safety of varenicline as an aid to smoking cessation in methadone-maintained smokers." | 5.19 | Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial. ( Arnsten, JH; Nahvi, S; Ning, Y; Richter, KP; Segal, KS, 2014) |
| "Tobacco cessation medication adherence is one of the few factors shown to improve smoking cessation rates among methadone-maintained smokers, but interventions to improve adherence to smoking cessation medications have not yet been tested among methadone treatment patients." | 5.19 | Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. ( Arnsten, JH; Litwin, AH; Nahvi, S; Segal, KS, 2014) |
| "We test, using a three-group randomized design, the efficacy of varenicline versus placebo, in comparison with nicotine replacement therapy (NRT) that combines nicotine patch prescription plus ad libitum nicotine rescue, for smoking cessation." | 5.17 | Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. ( Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD, 2013) |
| "This study evaluated the efficacy of a contingency management (CM) intervention to promote smoking cessation in methadone-maintained patients." | 5.13 | Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. ( Dunn, KE; Heil, SH; Higgins, ST; Sigmon, SC; Thomas, CS, 2008) |
| "To test, in combination with the nicotine patch, the incremental efficacy of a maximal, tailored behavioral treatment over a minimal treatment for smoking cessation." | 5.12 | A smoking cessation intervention for the methadone-maintained. ( Anderson, BJ; Anthony, JL; Herman, DS; Niaura, R; Stein, MD; Weinstock, MC, 2006) |
| "To determine predictors of smoking cessation duration in a randomized clinical trial, we assigned participants to nicotine patch (8-12 weeks) plus either (a) a baseline tailored brief motivational intervention, a quit date behavioral skills counseling session, and a relapse prevention follow-up session, or (b) brief advice using the National Cancer Institute's 4A's model." | 5.12 | Smoking cessation patterns in methadone-maintained smokers. ( Anderson, BJ; Niaura, R; Stein, MD, 2007) |
| "Between February 2002 and May 2004 we recruited 383 smokers from 5 methadone maintenance programs for a randomized trial of nicotine replacement plus behavioral treatment versus nicotine replacement alone for smoking cessation." | 5.11 | Respiratory symptom relief related to reduction in cigarette use. ( Anderson, BJ; Herman, DS; Stein, MD; Weinstock, MC, 2005) |
| "To evaluate relapse prevention (relapse prevention) and contingency management (contingency management) for optimizing smoking cessation outcomes using nicotine replacement therapy for methadone-maintained tobacco smokers." | 5.10 | Smoking cessation in methadone maintenance. ( Frosch, D; Jarvik, ME; Ling, W; Nahom, D; Rawson, RA; Rotheram-Fuller, E; Shoptaw, S; Yang, X, 2002) |
| "The relationship between tobacco and illicit drug use was examined among 166 methadone-maintained persons participating in a smoking cessation intervention." | 5.10 | Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained. ( Frosch, DL; Shoptaw, S; Stein, JA, 2002) |
| " This review summarizes existing knowledge about smoking cessation treatments for pregnant women on buprenorphine or methadone, the two forms of medication-assisted treatment for opioid use disorder indicated for prenatal use." | 4.91 | Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review. ( Akerman, SC; Blunt, HB; Brunette, MF; Goodman, DJ; Green, AI; Heil, SH, 2015) |
| " In this commentary, we briefly summarize the extant literature on pharmacotherapies in opioid-maintained smokers and contribute new data investigating the contribution of bupropion on smoking outcomes in 81 methadone- and buprenorphine-maintained participants from two randomized trials of financial incentives for smoking cessation." | 4.91 | Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions. ( Miller, ME; Sigmon, SC, 2015) |
| "Individuals in methadone maintenance treatment are motivated to quit smoking and are interested in smoking cessation treatment." | 4.86 | Smoking cessation interventions among individuals in methadone maintenance: a brief review. ( Barr, AM; Greaves, L; Johnson, JL; Khara, M; Okoli, CT; Procyshyn, RM, 2010) |
| " This method has found smoking cessation and methadone maintenance to be highly cost-effective health care programs." | 4.80 | The cost-effectiveness of substance abuse treatment. ( Barnett, PG, 1999) |
| "Pregnant smokers recruited to participate in a placebo-controlled trial of bupropion for smoking cessation provided a blood sample for measurement of NMR." | 3.96 | Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study. ( Hand, D; Kranzler, HR; Lynch, KG; Oncken, C; Schnoll, R; Tyndale, RF; Washio, Y; Zindel, LR, 2020) |
| "Smoking cessation treatment service is concerned to be a critical element in methadone maintenance treatment (MMT) in order to diminish the effect of smoke on health outcomes." | 3.81 | Motivation for smoking cessation among drug-using smokers under methadone maintenance treatment in Vietnam. ( Do, HP; Dunne, M; Latkin, C; Nguyen, LH; Nguyen, NP; Phan, HT; Tran, BX, 2015) |
| "Over 80% of people in methadone treatment smoke cigarettes, and existing smoking cessation interventions have been minimally effective." | 3.81 | Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment. ( Bernstein, SL; Cooperman, NA; Richter, KP; Steinberg, ML; Williams, JM, 2015) |
| " Methadone patients will likely experience little harm and a great deal of benefit from treatment with varenicline for smoking cessation." | 3.79 | Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness. ( Arnsten, JH; Bernstein, SL; Nahvi, S; Richter, KP; Wu, B, 2013) |
| "The need for research to develop and test tailored interventions for this population is highlighted, as is the need for methadone services and staff to facilitate client smoking cessation." | 3.78 | Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action. ( Bartlem, K; Bowman, J; Colyvas, K; Walsh, RA; Wiggers, J; Wye, P, 2012) |
| "To report the potential clinically significant pharmacokinetic interaction that may result from smoking cessation in patients on methadone maintenance therapy." | 3.77 | Methadone toxicity due to smoking cessation--a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2. ( Kolluru, S; Molina, C; Nguyen, T; Speake, J; Wahawisan, J, 2011) |
| "Our data show a higher level of nicotine dependence and depression, and greater readiness to change among women smokers in methadone maintenance programmes compared to women smokers attending primary care clinics." | 3.76 | Nicotine dependence and depression among women smokers on methadone maintenance. ( Arnold, S; Gandhi, D; Joshi, A; Khanna, N; Sadaphal, S; Stewart, D, 2010) |
| " A carbon monoxide longitudinal data set in a smoking cessation study is used for illustration." | 3.73 | Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial. ( Shoptaw, S; Yang, X, 2005) |
| " In multivariate analyses, lower nicotine dependence, prior use of smoking cessation pharmacotherapy, and lower methadone dose were associated with being in the preparation stage." | 3.73 | Cigarette smoking and interest in quitting in methadone maintenance patients. ( Arnsten, J; Li, X; Modali, L; Nahvi, S; Richter, K, 2006) |
| "There was described and discussed a case of methadone maintenance participant, former polydrug abuser, who has received a standard treatment with bupropion SR for smoking cessation." | 3.73 | [Bupropion in cigarettes smoking cessation by former polydrug user participating in methadone maintenance programme]. ( Habrat, B; Steinbarth-Chmielewska, K, 2005) |
| " In the 30 days before the survey, respondents reported that their clinics provided the following services to at least one patient: 73 percent provided brief advice to quit, 18 percent offered individual or group smoking cessation counseling, and 12 percent prescribed nicotine replacement therapy." | 3.72 | Smoking cessation services in U.S. methadone maintenance facilities. ( Ahluwalia, JS; Choi, WS; Harris, KJ; McCool, RM; Richter, KP, 2004) |
| "Several studies have shown high levels of interest in smoking cessation among methadone maintained heroin users, yet little is known about how to intervene most effectively with this population." | 3.71 | Optimizing smoking cessation outcomes among the methadone maintained. ( Frosch, DL; Nahom, D; Shoptaw, S, 2002) |
| "We describe the degree of nicotine addiction and readiness to quit smoking among people with a history of injection drug use, comparing those in a methadone maintenance treatment program (MMTP) with active illicit drug injectors in a needle exchange program (NEP)." | 3.71 | Interest in smoking cessation among injection drug users. ( Clarke, JG; Gogineni, A; McGarry, KA; Stein, MD, 2001) |
| " Because a history of depression has been shown in other populations to complicate cessation efforts, the relationship between depression and nicotine dependence was tested in 726 methadone patients." | 3.69 | Nicotine dependence and depression among methadone maintenance patients. ( Brown, LS; Lin, MM; Meyer, TJ, 1996) |
| "Methadone maintenance treatment (MMT) patients have an exceedingly high prevalence of tobacco use, and interventions that have been specifically developed for this vulnerable subpopulation have struggled to attain even modest rates of cessation." | 2.79 | Early quit days among methadone-maintained smokers in a smoking cessation trial. ( Anderson, BJ; Caviness, CM; de Dios, MA; Stein, MD, 2014) |
| "Nicotine plasma levels were highest on the cigarette smoking day (P < 0." | 2.74 | Methadone-nicotine interactions in methadone maintenance treatment patients. ( Brands, B; Elkader, AK; Selby, P; Sproule, BA, 2009) |
| " Participants smoked a greater proportion of cigarettes in their first 2-hr block after methadone dosing (M = 0." | 2.73 | Patterns of smoking and methadone dose in drug treatment patients. ( Catley, D; Cox, LS; Grobe, J; Hall, S; Hamilton, AK; Richter, KP, 2007) |
| "Nicotine use disorder is highly prevalent among methadone maintenance patients with its tobacco-related problems." | 2.58 | Smoking Cessation Among Methadone-Maintained Patients: A Meta-Analysis. ( Hoong, MC; Joyce, YC; Loh, HS; Yee, A, 2018) |
| "Methadone is a long-acting opioid agonist that is frequently prescribed as a treatment for opioid addiction." | 2.52 | Methadone's effect on nAChRs--a link between methadone use and smoking? ( Salminen, O; Talka, R; Tuominen, RK, 2015) |
| "Although individuals in substance use disorders (SUD) treatment continue to smoke at high rates, regulatory, policy and programming changes promoting tobacco cessation are being implemented and some patients quit successfully." | 1.46 | Quitting smoking during substance use disorders treatment: Patient and treatment-related variables. ( Campbell, BK; Guydish, J; Le, T; Tajima, B, 2017) |
| "Five methadone maintenance treatment centers." | 1.33 | Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers. ( Anderson, BJ; Niaura, R; Stein, MD, 2006) |
| "When methadone and puffs were concurrently available, an increase in methadone's price decreased puff consumption, and demand for methadone was less elastic than when puffs were not concurrently available." | 1.33 | Methadone and nicotine self-administration in humans: a behavioral economic analysis. ( Cowan, K; Hursh, S; Martinetti, MP; Meisch, RA; Spiga, R, 2005) |
| "Most substance abuse treatment facilities do not routinely treat cigarette smoking even though most of their clients smoke and many will die from tobacco-related illness." | 1.33 | Good and bad times for treating cigarette smoking in drug treatment. ( Richter, KP, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (11.94) | 18.2507 |
| 2000's | 30 (44.78) | 29.6817 |
| 2010's | 26 (38.81) | 24.3611 |
| 2020's | 3 (4.48) | 2.80 |
| Authors | Studies |
|---|---|
| Ware, OD | 1 |
| Sweeney, MM | 1 |
| Cunningham, C | 1 |
| Umbricht, A | 1 |
| Stitzer, M | 2 |
| Dunn, KE | 2 |
| Kranzler, HR | 1 |
| Washio, Y | 1 |
| Zindel, LR | 1 |
| Lynch, KG | 1 |
| Hand, D | 1 |
| Tyndale, RF | 1 |
| Oncken, C | 1 |
| Schnoll, R | 1 |
| Nahvi, S | 6 |
| Adams, TR | 1 |
| Ning, Y | 2 |
| Zhang, C | 1 |
| Arnsten, JH | 4 |
| Yee, A | 1 |
| Hoong, MC | 1 |
| Joyce, YC | 1 |
| Loh, HS | 1 |
| Cooperman, NA | 2 |
| Lu, SE | 1 |
| Richter, KP | 11 |
| Bernstein, SL | 3 |
| Williams, JM | 2 |
| Zirakzadeh, A | 1 |
| Shuman, C | 1 |
| Stauter, E | 1 |
| Hays, JT | 1 |
| Ebbert, JO | 1 |
| Stein, MD | 11 |
| Caviness, CM | 3 |
| Kurth, ME | 1 |
| Audet, D | 2 |
| Olson, J | 1 |
| Anderson, BJ | 10 |
| Segal, KS | 3 |
| Litwin, AH | 1 |
| de Dios, MA | 2 |
| Steinberg, ML | 1 |
| Akerman, SC | 1 |
| Brunette, MF | 1 |
| Green, AI | 1 |
| Goodman, DJ | 1 |
| Blunt, HB | 1 |
| Heil, SH | 2 |
| Griffin, JL | 1 |
| Miller, ME | 1 |
| Sigmon, SC | 2 |
| Talka, R | 1 |
| Tuominen, RK | 1 |
| Salminen, O | 1 |
| Tran, BX | 1 |
| Nguyen, LH | 1 |
| Do, HP | 1 |
| Nguyen, NP | 1 |
| Phan, HT | 1 |
| Dunne, M | 1 |
| Latkin, C | 1 |
| Caviness, C | 1 |
| Grimone, K | 1 |
| Bailey, GL | 1 |
| Winhusen, T | 1 |
| Theobald, J | 1 |
| Lewis, D | 1 |
| Campbell, BK | 2 |
| Le, T | 1 |
| Tajima, B | 2 |
| Guydish, J | 2 |
| Finkelstein, J | 1 |
| Lapshin, O | 1 |
| Cha, E | 1 |
| Thomas, CS | 1 |
| Higgins, ST | 1 |
| Elkader, AK | 1 |
| Brands, B | 1 |
| Selby, P | 1 |
| Sproule, BA | 1 |
| Okoli, CT | 1 |
| Khara, M | 1 |
| Procyshyn, RM | 1 |
| Johnson, JL | 1 |
| Barr, AM | 1 |
| Greaves, L | 1 |
| Li, L | 1 |
| Liu, Y | 1 |
| Zhang, Y | 1 |
| Beveridge, TJ | 1 |
| Zhou, W | 1 |
| Khanna, N | 1 |
| Arnold, S | 1 |
| Sadaphal, S | 1 |
| Joshi, A | 1 |
| Stewart, D | 1 |
| Gandhi, D | 1 |
| Wahawisan, J | 1 |
| Kolluru, S | 1 |
| Nguyen, T | 1 |
| Molina, C | 1 |
| Speake, J | 1 |
| Reid, MS | 1 |
| Jiang, H | 1 |
| Fallon, B | 1 |
| Sonne, S | 1 |
| Rinaldi, P | 1 |
| Turrigiano, E | 1 |
| Arfken, C | 1 |
| Robinson, J | 1 |
| Rotrosen, J | 1 |
| Nunes, EV | 1 |
| Bowman, J | 1 |
| Wiggers, J | 1 |
| Colyvas, K | 1 |
| Wye, P | 1 |
| Walsh, RA | 1 |
| Bartlem, K | 1 |
| Kulaga, A | 1 |
| Zavala, R | 1 |
| Brown, LS | 2 |
| Bostrom, A | 1 |
| Ziedonis, D | 1 |
| Chan, M | 1 |
| Stanton, CA | 1 |
| Niaura, R | 5 |
| Stein, M | 1 |
| Tuten, M | 1 |
| Fitzsimons, H | 1 |
| Chisolm, MS | 1 |
| Nuzzo, PA | 1 |
| Jones, HE | 1 |
| Wu, B | 1 |
| Frosch, DL | 3 |
| Stein, JA | 1 |
| Shoptaw, S | 5 |
| Rotheram-Fuller, E | 1 |
| Yang, X | 2 |
| Frosch, D | 1 |
| Nahom, D | 2 |
| Jarvik, ME | 2 |
| Rawson, RA | 2 |
| Ling, W | 2 |
| McCool, RM | 4 |
| Okuyemi, KS | 1 |
| Mayo, MS | 1 |
| Ahluwalia, JS | 5 |
| Paschall Richter, K | 1 |
| Spiga, R | 2 |
| Martinetti, MP | 1 |
| Meisch, RA | 1 |
| Cowan, K | 1 |
| Hursh, S | 1 |
| Choi, WS | 1 |
| Harris, KJ | 1 |
| Shadel, WG | 1 |
| Herman, DS | 3 |
| Bishop, S | 1 |
| Lassor, JA | 1 |
| Weinstock, M | 1 |
| Anthony, JL | 3 |
| Hayaki, J | 1 |
| Olsen, Y | 1 |
| Alford, DP | 1 |
| Horton, NJ | 1 |
| Saitz, R | 1 |
| Baran-Furga, H | 1 |
| Chmielewska, K | 1 |
| Bogucka-Bonikowska, A | 1 |
| Habrat, B | 2 |
| Kostowski, W | 1 |
| Bienkowski, P | 1 |
| Weinstock, MC | 3 |
| Shah, NG | 1 |
| Galai, N | 1 |
| Celentano, DD | 1 |
| Vlahov, D | 1 |
| Strathdee, SA | 1 |
| Catley, D | 2 |
| Hall, M | 1 |
| Richter, K | 1 |
| Li, X | 1 |
| Modali, L | 1 |
| Arnsten, J | 1 |
| Steinbarth-Chmielewska, K | 1 |
| Hamilton, AK | 1 |
| Hall, S | 1 |
| Cox, LS | 1 |
| Grobe, J | 1 |
| Stark, MJ | 1 |
| Meyer, TJ | 1 |
| Lin, MM | 1 |
| Clemmey, P | 1 |
| Brooner, R | 1 |
| Chutuape, MA | 1 |
| Kidorf, M | 1 |
| Schmitz, J | 1 |
| Day, J | 1 |
| Wodak, A | 1 |
| Barnett, PG | 1 |
| Gibson, CA | 1 |
| Schmelzle, KH | 1 |
| Clarke, JG | 1 |
| McGarry, KA | 1 |
| Gogineni, A | 1 |
| Haug, NA | 1 |
| Stitzer, ML | 1 |
| Svikis, DS | 1 |
| Havassy, BE | 1 |
| Hall, SM | 1 |
| Wasserman, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients[NCT01378858] | 100 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
| Varenicline Versus Nicotine Replacement for Methadone-Maintained Smokers[NCT00790569] | 315 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
| Smoking Cessation Treatment for Methadone Maintenance Patients[NCT01027754] | Phase 4 | 112 participants (Actual) | Interventional | 2009-08-31 | Completed | ||
| Effectiveness of an Information-Motivation-Behavioral Skills Model-based Intervention on Adherence to Domiciliary Non-invasive Ventilation of Patients With Chronic Hypercapnic Respiratory Failure: A Randomized Controlled Study[NCT05008211] | 104 participants (Anticipated) | Interventional | 2021-09-16 | Recruiting | |||
| Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination[NCT01493258] | 0 participants (Actual) | Interventional | 2010-08-31 | Withdrawn (stopped due to PI left JHU and is not able to be reached for updates) | |||
| Telemedicine for Smoking Cessation in Rural Primary Care[NCT00843505] | Phase 3 | 566 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| An Innovative Digital Smoking Cessation Intervention for Low-Income Adults With Substance Use Disorder[NCT04419922] | 100 participants (Actual) | Observational | 2020-04-02 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants achieving self reported, seven day point prevalence abstinence, biochemically verified with expired carbon monoxide (CO) < 8 p.p.m., missing = smoking (NCT01378858)
Timeframe: Week 12 of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline Treatment as Usual (TAU) | 9 |
| Varenicline Directly Observed Therapy | 5 |
Number of participants achieving self reported, seven day point prevalence abstinence, biochemically verified with expired carbon monoxide (CO) < 8 p.p.m. (NCT01378858)
Timeframe: 24 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline Treatment as Usual (TAU) | 6 |
| Varenicline Directly Observed Therapy | 2 |
Pill count adherence, measured as pills taken divided by pills dispensed, analyzed as a continuous measure (NCT01378858)
Timeframe: Weeks 0-1, 1-2, 2-3, 4-6, 7-9, 10-12
| Intervention | percentage pills taken/pills dispensed (Mean) |
|---|---|
| Varenicline Treatment as Usual (TAU) | 61.8 |
| Varenicline Directly Observed Therapy | 78.5 |
Number of participants reporting 7-day abstinence at 6-months, confirmed with CO measurement. (NCT00790569)
Timeframe: 6-Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 5 |
| Arm II | 1 |
| Arm III | 11 |
Change in mean cigarettes per day (NCT00790569)
Timeframe: 6-Months
| Intervention | cigarettes/day (Mean) |
|---|---|
| Arm I | -8.7 |
| Arm II | -8.5 |
| Arm III | -7.8 |
Smoking urges was measured on a 0 (not at all) - 100 (strongest feeling possible) scale. Higher values represent greater urge to smoke. Change in smoking urges was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -29.971 |
| Arm II | -25.015 |
| Arm III | -24.177 |
Number of participants reporting 7-day abstinence at 12-months, confirmed with CO measurement. (NCT00790569)
Timeframe: 12 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 4 |
| Arm II | 1 |
| Arm III | 8 |
Number of participants who self-reported continuous abstinence from their initial quit day (study day 14) to 6 Months (NCT00790569)
Timeframe: 6-Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 2 |
| Arm II | 0 |
| Arm III | 2 |
Reinforcing effects of smoking was measured using the modified version of the Cigarette Evaluation Questionnaire. Participants were asked to indicate on a 12-item scale how smoking made them feel in the prior 30 days on a scale from 1 (Not at all) to 7 (Extremely). Higher values indicated that smoking was a more positive experience for 10 of 12 items. Two items were reverse coded. Change in reinforcing effects of smoking was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -1.005 |
| Arm II | -.683 |
| Arm III | -.761 |
Number of participants with self-reported, 7-day abstinence at 6-months (NCT00790569)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 11 |
| Arm II | 3 |
| Arm III | 16 |
Number of participants with self-reported 7-day abstinence at 12-months (NCT00790569)
Timeframe: 12 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 4 |
| Arm II | 3 |
| Arm III | 11 |
Withdrawal Symptoms were measured using a modified version of the Minnesota Behavior Rating Scale. The scale asked subjects to rate their smoking withdrawal symptoms over the previous 24 hours on a scale from 0 (none) to 4 (severe). Higher values indicate more severe withdrawal symptoms. Change in withdrawal symptoms was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -.222 |
| Arm II | -.163 |
| Arm III | -.113 |
(NCT01027754)
Timeframe: Week 12
| Intervention | participants (Number) |
|---|---|
| Varenicline | 6 |
| Placebo | 0 |
(NCT01027754)
Timeframe: Week 24
| Intervention | participants (Number) |
|---|---|
| Varenicline | 3 |
| Placebo | 0 |
Participants were offered 5 counseling visits at weeks 0, 2, 4, 8, 12. (NCT01027754)
Timeframe: End of 12 week intervention period
| Intervention | visits completed (Mean) |
|---|---|
| Varenicline | 1.96 |
| Placebo | 1.85 |
Mean number of study visit completed out of a possible total of 6 study visits at weeks 0, 2, 4, 8, 12 and 24. (NCT01027754)
Timeframe: 24 weeks
| Intervention | visits completed (Mean) |
|---|---|
| Varenicline | 5.72 |
| Placebo | 5.36 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change in taste | Dry Mouth | Change in appetite | Nausea | Vomiting | Gas | Constipation | Change in concentration | Headache | Fatigue | Insomnia | Dizziness | Irritability | Vivid/more frequent dreams | |
| Placebo | 14 | 23 | 18 | 14 | 8 | 15 | 9 | 6 | 18 | 13 | 13 | 8 | 8 | 22 |
| Varenicline | 18 | 27 | 29 | 29 | 11 | 19 | 23 | 6 | 11 | 15 | 15 | 9 | 10 | 18 |
Confidence of quitting smoking measure on a scale of 1-10 (10= high levels of quit confidence). (NCT01027754)
Timeframe: Weeks 2, 4, 8, 12, and 24
| Intervention | units on a scale (Median) | ||||
|---|---|---|---|---|---|
| At week 2 | At week 4 | At week 8 | At week 12 | At week 24 | |
| Placebo | 8 | 8 | 9 | 8 | 8 |
| Varenicline | 8 | 9 | 9 | 9 | 8 |
Importance of quitting smoking measured on a scale of 1-10 (10=high levels of quit importance). (NCT01027754)
Timeframe: Weeks 2, 4, 8, 12, and 24
| Intervention | units on a scale (Median) | ||||
|---|---|---|---|---|---|
| At week 2 | At week 4 | At week 8 | At week 12 | At week 24 | |
| Placebo | 10 | 10 | 10 | 10 | 10 |
| Varenicline | 10 | 10 | 10 | 10 | 10 |
(NCT01027754)
Timeframe: Weeks 2, 4, 8, 12, and 24
| Intervention | cigarettes/day (Median) | ||||
|---|---|---|---|---|---|
| At week 2 | At week 4 | At week 8 | At week 12 | At week 24 | |
| Placebo | 6 | 5 | 5 | 5 | 5 |
| Varenicline | 3 | 2 | 3 | 2 | 4 |
(NCT01027754)
Timeframe: Weeks 2, 4, 8, 12, and 24
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| At week 2 | At week 4 | At week 8 | At week 12 | At week 24 | |
| Placebo | 25 | 27 | 32 | 25 | 30 |
| Varenicline | 33 | 35 | 37 | 37 | 41 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 8 | Week 12 | Week 24 | |
| Placebo | 0 | 0 | 0 | 1 | 2 |
| Varenicline | 0 | 0 | 2 | 0 | 2 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 8 | Week 12 | Week 24 | |
| Placebo | 0 | 0 | 0 | 0 | 0 |
| Varenicline | 0 | 0 | 0 | 0 | 0 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 8 | Week 12 | Week 24 | |
| Placebo | 2 | 0 | 0 | 1 | 1 |
| Varenicline | 0 | 0 | 1 | 1 | 2 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 8 | Week 12 | Week 24 | |
| Placebo | 11 | 7 | 7 | 5 | 5 |
| Varenicline | 9 | 4 | 6 | 8 | 5 |
(NCT01027754)
Timeframe: over the intervention period (measured at weeks 2, 4, 8, 12, and 24)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 8 | Week 12 | Week 24 | |
| Placebo | 1 | 0 | 1 | 2 | 1 |
| Varenicline | 1 | 1 | 1 | 1 | 1 |
8 reviews available for methadone and Smoking Cessation
| Article | Year |
|---|---|
Smoking Cessation Among Methadone-Maintained Patients: A Meta-Analysis.
Topics: Combined Modality Therapy; Humans; Methadone; Opiate Substitution Treatment; Psychotherapy; Smoking | 2018 |
Cigarette smoking in methadone maintained patients: an up-to-date review.
Topics: Behavior, Addictive; Drug Interactions; Humans; Methadone; Narcotics; Nicotine; Nicotinic Agonists; | 2013 |
Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.
Topics: Analgesics, Opioid; Behavior Therapy; Buprenorphine; Female; Humans; Methadone; Opiate Substitution | 2015 |
Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.
Topics: Analgesics, Opioid; Bupropion; Forecasting; Humans; Methadone; Opioid-Related Disorders; Randomized | 2015 |
Methadone's effect on nAChRs--a link between methadone use and smoking?
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics, Opioid; Humans; Methadone; Nicotinic Agonists; | 2015 |
Smoking cessation interventions among individuals in methadone maintenance: a brief review.
Topics: Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Smoking; Smoking Cessation; So | 2010 |
A case for addressing cigarette use in methadone and other opioid treatment programs.
Topics: Humans; Methadone; Narcotics; Opioid-Related Disorders; Prevalence; Psychotherapy, Brief; Regional M | 2000 |
The cost-effectiveness of substance abuse treatment.
Topics: Cost-Benefit Analysis; Health Care Costs; Humans; Methadone; Narcotics; Quality-Adjusted Life Years; | 1999 |
24 trials available for methadone and Smoking Cessation
| Article | Year |
|---|---|
Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
Topics: Bupropion; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Humans; Male; Methadone; | 2023 |
Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial.
Topics: Directly Observed Therapy; Female; Humans; Male; Methadone; Middle Aged; Smokers; Smoking Cessation; | 2021 |
Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.
Topics: Adult; Analgesics, Opioid; Behavior Therapy; Female; Humans; Male; Methadone; Middle Aged; Nicotine; | 2018 |
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Depende | 2013 |
Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.
Topics: Benzazepines; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; New York City; Nico | 2014 |
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics.
Topics: Adult; Benzazepines; Cross-Sectional Studies; Directly Observed Therapy; Female; Follow-Up Studies; | 2014 |
Early quit days among methadone-maintained smokers in a smoking cessation trial.
Topics: Adult; Benzazepines; Female; Humans; Male; Medication Adherence; Methadone; Middle Aged; Opiate Subs | 2014 |
Barriers to Telephone Quitline Use Among Methadone-Maintained Smokers.
Topics: Adult; Cell Phone; Female; Hotlines; Humans; Male; Methadone; Middle Aged; New York; Opiate Substitu | 2015 |
An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Methadone; Middle Aged; Opiate Su | 2016 |
Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Clinical Protocols; Cross-Over Studi | 2016 |
Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study.
Topics: Adult; Cocaine-Related Disorders; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male | 2008 |
Methadone-nicotine interactions in methadone maintenance treatment patients.
Topics: Adult; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcoti | 2009 |
Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.
Topics: Adult; Age Factors; Alcoholism; Community Health Services; Ethnicity; Female; Humans; Male; Methadon | 2011 |
The social support and social network characteristics of smokers in methadone maintenance treatment.
Topics: Adult; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Self Efficacy; S | 2013 |
Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial.
Topics: Adult; Behavior Therapy; Carbon Monoxide; Feasibility Studies; Female; Humans; Methadone; Motivation | 2012 |
Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained.
Topics: Behavior, Addictive; Clinical Trials as Topic; Heroin Dependence; Humans; Methadone; Models, Statist | 2002 |
Smoking cessation in methadone maintenance.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Nicotine; Smoking; | 2002 |
Respiratory symptom relief related to reduction in cigarette use.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Methadone; Respiratory Tract Diseases; Smoking Cessa | 2005 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Human | 2005 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Human | 2005 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Human | 2005 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Human | 2005 |
A smoking cessation intervention for the methadone-maintained.
Topics: Adult; Combined Modality Therapy; Female; Humans; Male; Methadone; Middle Aged; Nicotine; Opioid-Rel | 2006 |
Smoking cessation patterns in methadone-maintained smokers.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Confidence Intervals; Female; Humans; M | 2007 |
Relationship of depression to smoking outcomes in a methadone-maintained population.
Topics: Administration, Cutaneous; Adolescent; Adult; Depressive Disorder, Major; Diagnostic and Statistical | 2007 |
Patterns of smoking and methadone dose in drug treatment patients.
Topics: Adult; Drug Administration Schedule; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Retros | 2007 |
Effects of nicotine on methadone self-administration in humans.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Carbon Monoxide; Drug Interactions; Female; Heroin | 1998 |
35 other studies available for methadone and Smoking Cessation
| Article | Year |
|---|---|
Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study.
Topics: Analgesics, Opioid; Bupropion; Cotinine; Female; Humans; Methadone; Nicotine; Opiate Substitution Tr | 2020 |
Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment.
Topics: Adult; Female; Humans; Male; Methadone; Middle Aged; Models, Psychological; Motivation; Narcotics; O | 2015 |
Motivation for smoking cessation among drug-using smokers under methadone maintenance treatment in Vietnam.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Male; Methadone; Motivation; Opiate Substitution Tre | 2015 |
Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.
Topics: Adult; Ambulatory Care; Analgesics, Opioid; Female; Humans; Male; Methadone; Middle Aged; Opiate Sub | 2017 |
Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education.
Topics: Attitude to Health; Computers; Health Knowledge, Attitudes, Practice; Health Promotion; Health Surve | 2008 |
Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadone-maintained smokers.
Topics: Adult; China; Drug Interactions; Female; Heroin Dependence; Humans; Male; Methadone; Motivation; Nar | 2010 |
Nicotine dependence and depression among women smokers on methadone maintenance.
Topics: Adult; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Methadone; Middle Aged; N | 2010 |
Methadone toxicity due to smoking cessation--a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2.
Topics: Analgesics, Opioid; Cytochrome P-450 CYP1A2; Dose-Response Relationship, Drug; Drug Interactions; Hu | 2011 |
Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action.
Topics: Adult; Australia; Cross-Sectional Studies; Female; Heroin Dependence; Humans; Male; Methadone; Motiv | 2012 |
The New York policy on smoking in addiction treatment: findings after 1 year.
Topics: Adult; Female; Financing, Government; Health Knowledge, Attitudes, Practice; Health Personnel; Healt | 2012 |
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.
Topics: Benzazepines; Cardiovascular Diseases; Comorbidity; Data Interpretation, Statistical; Female; Humans | 2013 |
Optimizing smoking cessation outcomes among the methadone maintained.
Topics: Adult; Female; Heroin Dependence; Humans; Los Angeles; Male; Methadone; Middle Aged; Narcotics; Nico | 2002 |
Patients' views on smoking cessation and tobacco harm reduction during drug treatment.
Topics: Adult; Attitude to Health; Female; Harm Reduction; Humans; Male; Methadone; Motivation; Narcotics; S | 2002 |
Why do so many drug users smoke?
Topics: Adult; Causality; Comorbidity; Cross-Sectional Studies; Female; Focus Groups; Health Surveys; Heroin | 2003 |
Methadone and nicotine self-administration in humans: a behavioral economic analysis.
Topics: Adult; Choice Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interac | 2005 |
Smoking cessation services in U.S. methadone maintenance facilities.
Topics: Adult; Combined Modality Therapy; Comorbidity; Counseling; Cross-Sectional Studies; Female; Health S | 2004 |
Correlates of motivation to quit smoking in methadone-maintained smokers enrolled in a smoking cessation trial.
Topics: Adult; Attitude to Health; Cross-Sectional Studies; Female; Humans; Male; Methadone; Motivation; Opi | 2005 |
Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
Topics: Bias; Carbon Monoxide; Clinical Trials as Topic; Computer Graphics; Data Collection; Data Interpreta | 2005 |
Perceptions of health risk susceptibility in methadone maintained smokers.
Topics: Adult; Attitude to Health; Female; Health Status; Humans; Lung Neoplasms; Male; Methadone; Middle Ag | 2005 |
Addressing smoking cessation in methadone programs.
Topics: Adult; Demography; Female; Humans; Male; Methadone; Narcotics; Smoking Cessation; Smoking Prevention | 2005 |
Self-reported effects of methadone on cigarette smoking in methadone-maintained subjects.
Topics: Adult; Female; Humans; Male; Methadone; Poland; Self Disclosure; Smoking; Smoking Cessation; Surveys | 2005 |
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.
Topics: Adult; Baltimore; Cohort Studies; Female; HIV Infections; Humans; Ill-Housed Persons; Incidence; Lon | 2006 |
Cigarette smoking and interest in quitting in methadone maintenance patients.
Topics: Adult; Aged; Cross-Sectional Studies; Drug Administration Schedule; Female; Health Care Surveys; Hum | 2006 |
[Bupropion in cigarettes smoking cessation by former polydrug user participating in methadone maintenance programme].
Topics: Bupropion; Dopamine Uptake Inhibitors; Electroencephalography; Heroin Dependence; Humans; Male; Meth | 2005 |
Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers.
Topics: Administration, Topical; Adult; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Nic | 2006 |
Good and bad times for treating cigarette smoking in drug treatment.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Data Collection; Humans; Methadone; Smoking Cessat | 2006 |
Drug use and cigarette smoking in applicants for drug abuse treatment.
Topics: Adult; Alcoholism; Comorbidity; Female; Heroin Dependence; Humans; Male; Methadone; Oregon; Smoking; | 1993 |
Nicotine dependence and depression among methadone maintenance patients.
Topics: Adult; Aged; Depression; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Nicotine; Od | 1996 |
Smoking habits and attitudes in a methadone maintenance treatment population.
Topics: Adult; Ambulatory Care; Attitude to Health; Cohort Studies; Comorbidity; Female; Heroin Dependence; | 1997 |
Interest in smoking cessation among methadone maintained outpatients.
Topics: Adult; Ambulatory Care; Analgesics, Opioid; Female; Humans; Male; Marijuana Abuse; Methadone; Motiva | 1998 |
Harm reduction: Australia as a case study.
Topics: Alcoholism; Australia; Health Policy; HIV Infections; Humans; Illicit Drugs; Methadone; Needle-Excha | 1995 |
Tobacco use and quit attempts among methadone maintenance clients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Attitude to Health; Female; Health K | 2001 |
Interest in smoking cessation among injection drug users.
Topics: Adult; Female; Humans; Male; Methadone; Motivation; Narcotic Antagonists; Smoking Cessation; Substan | 2001 |
Smoking during pregnancy and intention to quit: a profile of methadone-maintained women.
Topics: Adult; Attitude to Health; Carbon Monoxide; Cotinine; Ethnicity; Female; Follow-Up Studies; Heroin D | 2001 |
Social support and relapse: commonalities among alcoholics, opiate users, and cigarette smokers.
Topics: Adult; Alcoholism; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Opioid-Related D | 1991 |